CHOP Plus Obinutuzumab Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C154213
A chemoimmunotherapy consisting of cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and obinutuzumab that can be used in the treatment of some forms of non-Hodgkin lymphoma (NHL). [ ]
Term info
Label
CHOP Plus Obinutuzumab Regimen
Synonyms
- CHOP + Obinutuzumab
- CHOP + Obinutuzumab Regimen
- CHOP Plus Obinutuzumab
- CHOP Plus Obinutuzumab Regimen
- CHOP-Obinutuzumab Regimen
- G-CHOP
- GCHOP
- Gazyva Plus CHOP
- Obinutuzumab Plus Cyclophosphamide/Doxorubicin/Vincristine/Prednisone
- Obinutuzumab-Cyclophosphamide-Doxorubicin-Prednisone-Vincristine
- Obinutuzumab-Cyclophosphamide-Doxorubicin-Prednisone-Vincristine Regimen
- Obinutuzumab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone
- Obinutuzumab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone Regimen
- Obinutuzumab/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine
- Obinutuzumab/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine Regimen
Subsets
NCIT_C160952, NCIT_C160950
NCI META CUI
CL555159
Preferred Name
CHOP Plus Obinutuzumab Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C154213
Term relations
Subclass of:
- Regimen Used to Treat Non-Hodgkin Lymphoma
- Chemotherapy_Regimen_Has_Component some Obinutuzumab
- Chemotherapy_Regimen_Has_Component some Vincristine
- Chemotherapy_Regimen_Has_Component some Doxorubicin
- Regimen_Has_Accepted_Use_For_Disease some Non-Hodgkin Lymphoma
- Chemotherapy_Regimen_Has_Component some Prednisone
- Chemotherapy_Regimen_Has_Component some Cyclophosphamide